Nightingale Health - New Blood on the Stock Market

[Antti_Luiro]

@Cle

@Antti_Luiro it would have been really interesting to hear about Innoquest’s outlook and their cooperation with the FWD insurance company in Malaysia. Or does discussing a partner’s partnerships go too far from NG itself?

The Pathology Asia/Innoquest entity would certainly have been interesting, but it was left off the question list this time due to prioritization, and the chat ended up being quite long anyway. We’ll get an update on this with figures in connection with the H2 report however, I would think that they would aim to report on any major steps forward in partnerships. And if this hasn’t been done, the default assumption is that progress has followed previous plans, meaning the partnership building has continued and no clear breakthrough has yet occurred.